F

Fusen Pharmaceutical Co Ltd
HKEX:1652

Watchlist Manager
Fusen Pharmaceutical Co Ltd
HKEX:1652
Watchlist
Price: 0.81 HKD -1.22% Market Closed
Market Cap: 598.8m HKD

Relative Value

The Relative Value of one Fusen Pharmaceutical Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.81 HKD, Fusen Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Fusen Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
84
Median 3Y
1.6
Median 5Y
1.7
Industry
2.7
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-3.2
Industry
21.6
vs History
63
vs Industry
Median 3Y
4.2
Median 5Y
8.2
Industry
16.9
vs History
44
vs Industry
Median 3Y
5.4
Median 5Y
5.4
Industry
22.9
vs History
36
vs Industry
77
Median 3Y
1.4
Median 5Y
1.5
Industry
2.3
vs History
34
vs Industry
79
Median 3Y
1.8
Median 5Y
1.9
Industry
3
vs History
23
vs Industry
79
Median 3Y
3.4
Median 5Y
4
Industry
5.6
vs History
vs Industry
Median 3Y
-9
Median 5Y
10.4
Industry
13.4
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
14.2
Industry
16.7
vs History
63
vs Industry
Median 3Y
4.4
Median 5Y
8.8
Industry
16.1
vs History
44
vs Industry
Median 3Y
4.7
Median 5Y
8.2
Industry
18.9
vs History
82
vs Industry
82
Median 3Y
0.6
Median 5Y
0.8
Industry
2

Multiples Across Competitors

Competitors Multiples
Fusen Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Fusen Pharmaceutical Co Ltd
HKEX:1652
598.8m HKD 2.2 -3.1 -59.3 -10.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
F
Fusen Pharmaceutical Co Ltd
HKEX:1652
Average P/E: 24.9
Negative Multiple: -3.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
F
Fusen Pharmaceutical Co Ltd
HKEX:1652
Average EV/EBITDA: 440
Negative Multiple: -59.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
F
Fusen Pharmaceutical Co Ltd
HKEX:1652
Average EV/EBIT: 1 883.6
Negative Multiple: -10.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5